Modelled DT Structure
Method: homology modeling
Template PDB: 5UJ9_A
Identity: 38.53%
Minimized Score: -2759.769 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0016 | ||||
Gene Name | ABCC5 | ||||
Protein Name | Multidrug resistance-associated protein 5 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 5UJ9_A Identity: 38.53% Minimized Score: -2759.769 kcal/mol Detail: Structure Info |
||||
Synonyms | ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11 | ||||
DT Family | ATP-Binding Cassette (ABC) Superfamily | ||||
Drug Conjugate Transporter (DCT) Family (ABCC) | |||||
Tissue Specificity | All isoforms are equally expressed in retina. | ||||
Function | This transporter acts as a multispecific organic anion pump which can transport nucleotide analogs. | ||||
Disease(s) | Colorectal cancer [ICD-11: 2B91] | ||||
Cytomegalovirus infections [ICD-11: 1D82] | |||||
Malignant pleural mesothelioma [ICD-11: 2C26.0] | |||||
Cholangiocarcinoma [ICD-11: 2C12.10] | |||||
Endogenous Substrate(s) | 5'-FUMP; 9-(2-phosphonylmethoxyethyl)adenine; Antimonial tartrate; Folic acids; Glutamate derivatives; Glutathione conjugates; Nucleoside analogues; Nucleotide analogues; Organoanions; Reduced folates; cAMP; cGMP | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 10 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Adenosine
|
Approved | Drug Info | Anxiety | MB24.3 | [1] |
Fluorescein
|
Approved | Drug Info | Ocular disease | 9E1Z | [2] |
Fluorouracil
|
Approved | Drug Info | Stomach cancer | 2B72 | [3] |
Folic acid
|
Approved | Drug Info | Vitamin deficiency | 5B55-5B7Z | [4] |
Ganciclovir
|
Approved | Drug Info | Cytomegalovirus infections | 1D82 | [5] |
Gemcitabine
|
Approved | Drug Info | Cholangiocarcinoma | 2C12.10 | [6] |
Irinotecan
|
Approved | Drug Info | Colorectal cancer | 2B91 | [7] |
Mercaptopurine
|
Approved | Drug Info | Acute lymphoblastic leukemia | 2B33.0 | [8] |
Methotrexate
|
Approved | Drug Info | Leukemia | 2A60-2B33 | [4] |
Pemetrexed
|
Approved | Drug Info | Malignant pleural mesothelioma | 2C26.0 | [9] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Octadecenylcarnitine | EM Info | Identified using HEK293 cells-ABCC5 | [10] | ||
Drug-DT Affinity Assessed by Cell Line |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 4 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
Folic acid | Approved | Drug Info | Human embryonic kidney cells (HEK293)-MRP5 | Km = 1000 microM | [4] |
Methotrexate | Approved | Drug Info | Human embryonic kidney cells (HEK293)-MRP5 | Km = 1174 microM | [9] |
Methotrexate | Approved | Drug Info | Human embryonic kidney cells (HEK293)-MRP5 | Km = 1200 microM | [4] |
Pemetrexed | Approved | Drug Info | Human embryonic kidney cells (HEK293)-MRP5 | Km = 281 microM | [9] |
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
Carboxydichlorofluorescein | Investigative | Drug Info | Human embryonic kidney cells (HEK293)-MRP5 | Km = 11.6 microM | [9] |
Cyclic adenosine monophosphate | Investigative | Drug Info | Chinese hamster V79 cells (V79)-MRP5 | Km = 379 microM | [11] |
References | |||||
1 | Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci. 2002;4(3):E14. | ||||
2 | Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem. 2007 Jul 20;282(29):20999-1004. | ||||
3 | ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology. 2009;9(1-2):136-44. | ||||
4 | The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res. 2005 May 15;65(10):4425-30. | ||||
5 | Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005;37(1):253-78. | ||||
6 | Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia. 2010 Sep;12(9):740-7. | ||||
7 | Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Curr Cancer Drug Targets. 2008 Aug;8(5):414-20. | ||||
8 | Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine. Springerplus. 2014 Dec 13;3:732. | ||||
9 | Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur J Pharm Sci. 2006 Apr;27(5):524-32. | ||||
10 | N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc Natl Acad Sci U S A. 2015 May 26;112(21):6601-6. | ||||
11 | The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem. 2000 Sep 29;275(39):30069-74. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.